BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25117488)

  • 1. Podocyte proteins in congenital and minimal change nephrotic syndrome.
    Suvanto M; Jahnukainen T; Kestilä M; Jalanko H
    Clin Exp Nephrol; 2015 Jun; 19(3):481-8. PubMed ID: 25117488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Mouse Model of Idiopathic Nephrotic Syndrome Induced by Immunization with the Podocyte Protein Crb2.
    Hada I; Shimizu A; Takematsu H; Nishibori Y; Kimura T; Fukutomi T; Kudo A; Ito-Nitta N; Kiuchi Z; Patrakka J; Mikami N; Leclerc S; Akimoto Y; Hirayama Y; Mori S; Takano T; Yan K
    J Am Soc Nephrol; 2022 Nov; 33(11):2008-2025. PubMed ID: 35985815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β1-Integrin blockade prevents podocyte injury in experimental models of minimal change disease.
    Cara-Fuentes G; Verma R; Venkatareddy M; Bauer C; Piani F; Aksoy ST; Vazzalwar N; Garcia GE; Banks M; Ordoñez FA; de Lucas-Collantes C; Bjornstad P; González Rodríguez JD; Johnson RJ; Garg P
    Nefrologia (Engl Ed); 2024; 44(1):90-99. PubMed ID: 37150673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.
    Chugh SS; Clement LC
    Am J Physiol Renal Physiol; 2023 Dec; 325(6):F685-F694. PubMed ID: 37795536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of B7-1 in podocytes is associated with nephrotic syndrome.
    Reiser J; von Gersdorff G; Loos M; Oh J; Asanuma K; Giardino L; Rastaldi MP; Calvaresi N; Watanabe H; Schwarz K; Faul C; Kretzler M; Davidson A; Sugimoto H; Kalluri R; Sharpe AH; Kreidberg JA; Mundel P
    J Clin Invest; 2004 May; 113(10):1390-7. PubMed ID: 15146236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.
    Kyrieleis HA; Löwik MM; Pronk I; Cruysberg HR; Kremer JA; Oyen WJ; van den Heuvel BL; Wetzels JF; Levtchenko EN
    Clin J Am Soc Nephrol; 2009 Oct; 4(10):1593-600. PubMed ID: 19808243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bicellular Localization of Tricellular Junctional Protein Angulin-3/ILDR2 Allows Detection of Podocyte Injury.
    Higashi AY; Saito AC; Higashi T; Furuse K; Furuse M; Chiba H; Kazama JJ
    Am J Pathol; 2024 May; 194(5):673-683. PubMed ID: 38311119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of calcitriol and methylprednisolone on podocytes function in minimal change disease in vitro model.
    Grubczak K; Starosz A; Makowska B; Parfienowicz Z; Krętowska M; Naumnik B; Moniuszko M
    Sci Rep; 2023 Aug; 13(1):12731. PubMed ID: 37543700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recessive
    Majmundar AJ; Buerger F; Forbes TA; Klämbt V; Schneider R; Deutsch K; Kitzler TM; Howden SE; Scurr M; Tan KS; Krzeminski M; Widmeier E; Braun DA; Lai E; Ullah I; Amar A; Kolb A; Eddy K; Chen CH; Salmanullah D; Dai R; Nakayama M; Ottlewski I; Kolvenbach CM; Onuchic-Whitford AC; Mao Y; Mann N; Nabhan MM; Rosen S; Forman-Kay JD; Soliman NA; Heilos A; Kain R; Aufricht C; Mane S; Lifton RP; Shril S; Little MH; Hildebrandt F
    Sci Adv; 2021 Jan; 7(1):. PubMed ID: 33523862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical characterization and insights into the oligomeric nature of CD2-associated protein.
    Qadri AH; Prajapati J; Faheem I; Bhattacharjee U; Padmanaban HK; Mulukala SK; Pasupulati AK
    Int J Biochem Mol Biol; 2024; 15(2):20-33. PubMed ID: 38765876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants." Kidney Int. 2023;103:962-972.
    Malakasioti G; Iancu D; Milovanova A; Tsygin A; Horinouchi T; Nagano C; Nozu K; Kamei K; Fujinaga S; Iijima K; Kang HG; Sinha R; Basu B; Morello W; Montini G; Waters A; Boyer O; Yıldırım ZY; Yel S; Dursun İ; McCarthy HJ; Vivarelli M; Prikhodina L; Besouw MTP; Chan EY; Huang W; Kemper MJ; Loos S; Prestidge C; Wong W; Zlatanova G; Ehren R; Weber LT; Chehade H; Hooman N; Tkaczyk M; Stańczyk M; Miligkos M; Tullus K;
    Kidney Int; 2024 Jan; 105(1):213-214. PubMed ID: 38182294
    [No Abstract]   [Full Text] [Related]  

  • 12. Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.
    Merscher S; Fornoni A
    Front Endocrinol (Lausanne); 2014; 5():127. PubMed ID: 25126087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte dedifferentiation: a specialized process for a specialized cell.
    May CJ; Saleem M; Welsh GI
    Front Endocrinol (Lausanne); 2014; 5():148. PubMed ID: 25324828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.
    Sinha A; Bhatia D; Gulati A; Rawat M; Dinda AK; Hari P; Bagga A
    Nephrol Dial Transplant; 2015 Jan; 30(1):96-106. PubMed ID: 25121488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review series: The cell biology of renal filtration.
    Scott RP; Quaggin SE
    J Cell Biol; 2015 Apr; 209(2):199-210. PubMed ID: 25918223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects of CRB2 cause steroid-resistant nephrotic syndrome.
    Ebarasi L; Ashraf S; Bierzynska A; Gee HY; McCarthy HJ; Lovric S; Sadowski CE; Pabst W; Vega-Warner V; Fang H; Koziell A; Simpson MA; Dursun I; Serdaroglu E; Levy S; Saleem MA; Hildebrandt F; Majumdar A
    Am J Hum Genet; 2015 Jan; 96(1):153-61. PubMed ID: 25557779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of podocyte adhesion for a healthy glomerulus.
    Lennon R; Randles MJ; Humphries MJ
    Front Endocrinol (Lausanne); 2014; 5():160. PubMed ID: 25352829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic target for nephrotic syndrome: Identification of novel slit diaphragm associated molecules.
    Fukusumi Y; Miyauchi N; Hashimoto T; Saito A; Kawachi H
    World J Nephrol; 2014 Aug; 3(3):77-84. PubMed ID: 25332898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic, size-selective effects of protamine sulfate and hyaluronidase on the rat glomerular filtration barrier in vivo.
    Sverrisson K; Axelsson J; Rippe A; Asgeirsson D; Rippe B
    Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1136-43. PubMed ID: 25209861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeability factors in focal and segmental glomerulosclerosis.
    Reiser J; Nast CC; Alachkar N
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):417-21. PubMed ID: 25168830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.